| Literature DB >> 25676592 |
Abstract
Pancreas transplantation is an accepted treatment for a subset of patients with diabetes mellitus, in particular those with renal failure who also require a kidney transplant and those with life-threatening hypoglycaemic unawareness. As results have improved and demand has risen, attention has focused on increasing the availability of pancreas transplantation by utilising pancreases from less than ideal donors, as well as addressing factors that limit the longevity of graft survival. The development of islet transplantation has posed additional demands on donor pancreas availability, as well as posing new challenges for donor organ allocation. This review focuses upon some of the current areas of interest in pancreatic transplantation.Entities:
Keywords: Cyclosporin (PubChem CID: 5284373); Diabetes mellitus; Everolimus (PubChem CID: 6442177); Mycophenolic acid (PubChem CID: 446541); Organ donation; Pancreas transplantation; Sirolimus (PubChem CID: 5284616); Tacrolimus (PubChem CID: 445643); Temsirolimus (PubChem CID: 6918289)
Mesh:
Year: 2015 PMID: 25676592 DOI: 10.1016/j.phrs.2015.01.005
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658